System Services Inc Danaher Corp GE Biopharma Gilead Sciences Inc Immunomedics inc Analog Devices Inc Maxim Integrated Products Inc Semiconductors Broadcom Inc CA Technologies Semiconductors IT Blackstone Real Estate GLP U S logistics assets Logistics Keurig Green Mountain JAB Holdings Dr Pepper Snapple Group Teladoc Inc Livongo Health Centene Corp WellCare Health Plans Inc Insurance
The Problem Through manipulation by pharmaceutical companies and pharmacy benefit managers, many essential medications have become more and more expensive over the years despite no real improvements. Insulin, for example, costs very little to make and is essential for diabetics to survive, but American patients find themselves paying thousands of dollars per month for it.[1]
problem by establishing a public insurance option, following recent laws in Washington (2019), Nevada (2021), Colorado (2021), and Minnesota (2023). While the insurance would not be a free public benefit, it would have key benefits: First, without the profit-maximizing incentives of most private health insurance companies today, a public insurance option would serve as a
largely unavailable to the public. Given President Biden's important pledge — and with public and policymaker concern about corporate concentration skyrocketing — Economic Liberties is publishing a detailed dataset of M&A activity that took place between January 2017 and January 2021. We relied on Mergr, among other sources, to collect and verify the data below.
power computing corp 1999: xemplar education and raycer graphics 2000: netselector, astarte-dvd authoring software, and soundjam mp 2001: bluefish labs, bluebuzz, spruce technologies and powerschool 2002: nothing real, zayante, silicon grail corp-chalice, propel software, prismo graphics and emagic 2005: schemasoft and fingerworks 2006: silicon color and proximity 2008: p.a. semi 2009: placebase and lala 2010: